MX2018007804A - Analogos de cortistatina y usos de los mismos. - Google Patents
Analogos de cortistatina y usos de los mismos.Info
- Publication number
- MX2018007804A MX2018007804A MX2018007804A MX2018007804A MX2018007804A MX 2018007804 A MX2018007804 A MX 2018007804A MX 2018007804 A MX2018007804 A MX 2018007804A MX 2018007804 A MX2018007804 A MX 2018007804A MX 2018007804 A MX2018007804 A MX 2018007804A
- Authority
- MX
- Mexico
- Prior art keywords
- human
- advantageous
- low
- cortistatin analogs
- administration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Abstract
Se proporcionan derivados de Cortistatina específicos con propiedades ventajosas para la administración in vivo en un huésped, que incluye un ser humano que lo necesita; estas nuevas especies tienen una farmacocinética ventajosa, baja toxicidad, actividad de hERG de baja a moderada y/o otras propiedades farmacológicas que las hacen destacar entre la clase de Cortistatinas como candidatos superiores para administración humana.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562387246P | 2015-12-23 | 2015-12-23 | |
US201662297494P | 2016-02-19 | 2016-02-19 | |
PCT/US2016/068125 WO2017112815A1 (en) | 2015-12-23 | 2016-12-21 | Cortistatin analogs and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018007804A true MX2018007804A (es) | 2019-07-04 |
Family
ID=59091204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018007804A MX2018007804A (es) | 2015-12-23 | 2016-12-21 | Analogos de cortistatina y usos de los mismos. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20180298024A1 (es) |
EP (1) | EP3394072A4 (es) |
JP (1) | JP2019508368A (es) |
KR (1) | KR20180095051A (es) |
CN (1) | CN108699085A (es) |
AU (1) | AU2016377678A1 (es) |
BR (1) | BR112018012647A2 (es) |
CA (1) | CA3009324A1 (es) |
CL (1) | CL2018001733A1 (es) |
CO (1) | CO2018007535A2 (es) |
EA (1) | EA201891511A1 (es) |
IL (1) | IL260123A (es) |
MX (1) | MX2018007804A (es) |
PH (1) | PH12018501351A1 (es) |
RU (1) | RU2018126984A (es) |
SG (1) | SG11201805092WA (es) |
WO (1) | WO2017112815A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20221048A1 (es) | 2015-07-02 | 2022-06-30 | Hoffmann La Roche | Lactamas biciclicas como inhibidores de rip1 cinasa |
JP7349359B2 (ja) | 2016-10-17 | 2023-09-22 | エフ. ホフマン-ラ ロシュ アーゲー | 二環式ピリドンラクタム及びその使用方法。 |
US11072607B2 (en) | 2016-12-16 | 2021-07-27 | Genentech, Inc. | Inhibitors of RIP1 kinase and methods of use thereof |
CN112074519A (zh) | 2018-04-20 | 2020-12-11 | 豪夫迈·罗氏有限公司 | 作为rip1激酶抑制剂用于治疗e.g.肠易激综合征(ibs)的n-[4-氧代-2,3-二氢-1,5-苯并氧氮杂-3-基]-5,6-二氢-4h-吡咯并[1,2-b]吡唑-2-甲酰胺衍生物和有关化合物 |
JP2022515705A (ja) * | 2018-11-01 | 2022-02-22 | サイロス ファーマシューティカルズ, インコーポレイテッド | サイクリン依存性キナーゼ7(cdk7)の非共有結合性阻害剤を用いてバイオマーカーにより特定された患者におけるがんを処置する方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642766B2 (en) * | 2008-05-05 | 2014-02-04 | Ryan A. Shenvi | Synthesis of (+) cortistatin A and related compounds |
WO2010024930A2 (en) * | 2008-08-28 | 2010-03-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses therof |
US20130217014A1 (en) * | 2012-02-17 | 2013-08-22 | Genentech, Inc. | Methods of using cdk8 antagonists |
WO2014123900A1 (en) * | 2013-02-05 | 2014-08-14 | Sirenas Marine Discovery | Anti-cancer and anti-hiv compounds |
CR20160291A (es) * | 2013-12-24 | 2017-02-24 | Harvard College | Análogos de cortistatina y síntesis y usos de los mismos |
-
2016
- 2016-12-21 JP JP2018532374A patent/JP2019508368A/ja active Pending
- 2016-12-21 CN CN201680082319.0A patent/CN108699085A/zh active Pending
- 2016-12-21 KR KR1020187020634A patent/KR20180095051A/ko unknown
- 2016-12-21 RU RU2018126984A patent/RU2018126984A/ru not_active Application Discontinuation
- 2016-12-21 AU AU2016377678A patent/AU2016377678A1/en not_active Abandoned
- 2016-12-21 EP EP16880055.5A patent/EP3394072A4/en not_active Withdrawn
- 2016-12-21 MX MX2018007804A patent/MX2018007804A/es unknown
- 2016-12-21 SG SG11201805092WA patent/SG11201805092WA/en unknown
- 2016-12-21 WO PCT/US2016/068125 patent/WO2017112815A1/en active Application Filing
- 2016-12-21 CA CA3009324A patent/CA3009324A1/en not_active Abandoned
- 2016-12-21 EA EA201891511A patent/EA201891511A1/ru unknown
- 2016-12-21 BR BR112018012647A patent/BR112018012647A2/pt not_active Application Discontinuation
-
2018
- 2018-06-18 IL IL260123A patent/IL260123A/en unknown
- 2018-06-22 US US16/016,199 patent/US20180298024A1/en not_active Abandoned
- 2018-06-22 CL CL2018001733A patent/CL2018001733A1/es unknown
- 2018-06-22 PH PH12018501351A patent/PH12018501351A1/en unknown
- 2018-07-18 CO CONC2018/0007535A patent/CO2018007535A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017112815A1 (en) | 2017-06-29 |
AU2016377678A1 (en) | 2018-07-12 |
EP3394072A1 (en) | 2018-10-31 |
EA201891511A1 (ru) | 2018-12-28 |
JP2019508368A (ja) | 2019-03-28 |
US20180298024A1 (en) | 2018-10-18 |
PH12018501351A1 (en) | 2019-02-27 |
KR20180095051A (ko) | 2018-08-24 |
RU2018126984A (ru) | 2020-01-23 |
CN108699085A (zh) | 2018-10-23 |
SG11201805092WA (en) | 2018-07-30 |
EP3394072A4 (en) | 2019-05-29 |
BR112018012647A2 (pt) | 2018-12-04 |
CL2018001733A1 (es) | 2018-11-09 |
IL260123A (en) | 2018-07-31 |
CO2018007535A2 (es) | 2018-07-31 |
CA3009324A1 (en) | 2017-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501351A1 (en) | Cortistatin analogs and uses thereof | |
PH12017502393A1 (en) | Glucagon derivative and a composition comprising a long acting conjugate of the same | |
NI201700096A (es) | Derivados de 4h-pirrol[3, 2-c]piridin-4-ona | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
CR20160501A (es) | Derivados de quinoxalina útiles como amortiguadores del receptor del factor de crecimiento de fibroblastos (fgfr) cinasa | |
PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
MX2016012994A (es) | Derivados de piridina macrociclicos. | |
MX2016009794A (es) | Derivado de sulfonamida heterociclico y medicina que comprende el mismo. | |
CL2017001100A1 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
MY181641A (en) | Amino pyran ring derivative and composition and use thereof | |
MX2017003476A (es) | Compuestos citotoxicos y anti-mitoticos, y metodos para usar los mismos. | |
UY37193A (es) | Nuevos compuestos antivíricos | |
MX2018015872A (es) | Derivados de benzodioxano y su uso farmaceutico. | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
PH12018501709A1 (en) | Naphthridinedione derivatives | |
MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
MX2016004393A (es) | Derivados de carboxamida como compuestos pesticidas. | |
WO2016048861A3 (en) | Heterocyclic compounds and use thereof | |
WO2014172363A3 (en) | Combretastatin analogs | |
MX2018004696A (es) | Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos. | |
MX2018009998A (es) | Analogos de cortistatina. | |
PH12017501869A1 (en) | (s)-2'-vinyl-abscisic acid derivatives | |
MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. |